Futures slip on renewed U.S.-China trade war concerns

Futures slip on renewed U.S.-China trade war concerns
(Reuters) – U.S. stock index futures dipped on Wednesday as a new U.S. bill taking a hard line on China stoked fresh concerns about a prolonged trade war, but more positive results from the banking sector provided some relief and signaled a solid start to the third-quarter earnings season. FILE PHOTO: Traders work on the floor at the New York... Read More

Ginkgo Bioworks raises $350 million fund for biotech spinouts

Ginkgo Bioworks raises $350 million fund for biotech spinouts
(Reuters) – Biotechnology start-up Ginkgo Bioworks said on Wednesday that it had raised a $350 million fund to more easily invest in spinout ventures that use its bio-engineering technology in a variety of industries that are just starting to use cutting edge biology. FILE PHOTO: Jason Kelly, Co-Founder and CEO of Ginkgo Bioworks, speaks during the Milken Institute’s 22nd annual... Read More

Trade angst, Brexit battle rattle European stocks, bond yields dip

Trade angst, Brexit battle rattle European stocks, bond yields dip
LONDON (Reuters) – European stocks sank and major bond yields nudged lower on Tuesday as concerns over China-U.S. trade talks, disappointing European company news and escalating tensions between London and Brussels sparked a flight to safety. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, October 7, 2019. REUTERS/Staff The pan-European STOXX 600... Read More

World stocks run out of steam amid trade jitters

World stocks run out of steam amid trade jitters
LONDON (Reuters) – A two-day global stocks rally ran out of steam on Tuesday while major bond yields came under pressure and the dollar was on the back foot as concerns over China-U.S. trade talks and disappointing European earnings doused investors’ optimism. The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, October 7,... Read More

Exclusive: Nasdaq cracks down on IPOs of small Chinese companies

Exclusive: Nasdaq cracks down on IPOs of small Chinese companies
(Reuters) – Nasdaq Inc (NDAQ.O) is cracking down on initial public offerings (IPOs) of small Chinese companies by tightening restrictions and slowing down their approval, according to regulatory filings, corporate executives and investment bankers. FILE PHOTO: Taxi cabs drive past the Nasdaq MarketSite in New York’s Times Square, August 23, 2013.REUTERS/Andrew Kelly/File Photo Nasdaq’s attempt to limit these stock market... Read More

European biotech firm BioNtech plans to raise nearly $304 million in U.S. IPO

European biotech firm BioNtech plans to raise nearly $304 million in U.S. IPO
FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski (Reuters) – BioNtech SE, Europe’s largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303.6 million in an initial public offering in the United States. The company expects its offering of about 15.2 million... Read More

Woodford director says $4 billion fund freeze continues

Woodford director says $4 billion fund freeze continues
LONDON (Reuters) – The suspension of money manager Neil Woodford’s Equity Income fund until December remains in place, the fund’s authorized corporate director said on Monday at its monthly review of the lock-up. FILE PHOTO: British fund manager Neil Woodford is seen in this undated handout image released July 18, 2019. Jonathan Atkins/Handout via REUTERS Link Fund Solutions froze the... Read More

Biotech is going to the dogs – and big profits await

Biotech is going to the dogs – and big profits await
(Reuters) – For Jessica Lescault there is no question that her 6-year old English bulldog “Moose” deserves cutting-edge biotechnology cancer treatment as much as any human patient. FILE PHOTO: Moose, a six-year-old English Bulldog with B-cell lymphoma, waits with his owner Jessica Lescault to receive trial medical treatment at the Tufts Veterinary Medical School in North Grafton, Massachusetts, U.S., September... Read More

Factbox: Animal health sector aims to emulate Zoetis biotech leap

Factbox: Animal health sector aims to emulate Zoetis biotech leap
(Reuters) – A commercial breakthrough in the field of complex therapeutic proteins for dogs by sector leader Zoetis (ZTS.N) has roused rivals to action in a hunt for biotechnology medicines to treat pets. Previously reserved for humans, biotech drugs made from genetically engineered living cells are now seen as ripe for the pet health market. The following are some of... Read More